Max Sauter

741 total citations
40 papers, 489 citations indexed

About

Max Sauter is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Max Sauter has authored 40 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Max Sauter's work include Drug Transport and Resistance Mechanisms (15 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Advanced Drug Delivery Systems (5 papers). Max Sauter is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Advanced Drug Delivery Systems (5 papers). Max Sauter collaborates with scholars based in Germany, United States and Canada. Max Sauter's co-authors include Walter Mier, Uwe Haberkorn, Jürgen Burhenne, Philipp Uhl, Walter E. Haefeli, Annette Altmann, Christel Herold‐Mende, Saskia Roesch, Helen Kühn and Gerhard Dyckhoff and has published in prestigious journals such as Analytical Biochemistry, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Max Sauter

39 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Sauter Germany	12	210	129	120	76	69	40	489
Hironori Kikkawa Japan	12	226 1.1×	127 1.0×	75 0.6×	49 0.6×	54 0.8×	23	418
Federica Bucci Italy	14	428 2.0×	168 1.3×	31 0.3×	23 0.3×	21 0.3×	18	622
Mohammad Zahid Kamran India	11	313 1.5×	227 1.8×	80 0.7×	8 0.1×	73 1.1×	12	679
Kazumasa Hasegawa Japan	7	174 0.8×	92 0.7×	46 0.4×	18 0.2×	62 0.9×	13	364
Lauren Price United States	13	210 1.0×	153 1.2×	85 0.7×	9 0.1×	54 0.8×	22	582
André Luiz Lourenço Brazil	13	134 0.6×	78 0.6×	30 0.3×	18 0.2×	105 1.5×	22	471
Tatsuaki Morokata Japan	16	206 1.0×	105 0.8×	69 0.6×	52 0.7×	303 4.4×	45	763
Michael V. Templin United States	19	429 2.0×	54 0.4×	15 0.1×	16 0.2×	74 1.1×	28	786
Gerd Nagel Germany	16	285 1.4×	190 1.5×	66 0.6×	19 0.3×	191 2.8×	34	675
Mostafa Erfani Iran	13	125 0.6×	107 0.8×	239 2.0×	7 0.1×	26 0.4×	75	525

Countries citing papers authored by Max Sauter

Since Specialization

Citations

This map shows the geographic impact of Max Sauter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Sauter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Sauter more than expected).

Fields of papers citing papers by Max Sauter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Sauter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Sauter. The network helps show where Max Sauter may publish in the future.

Co-authorship network of co-authors of Max Sauter

This figure shows the co-authorship network connecting the top 25 collaborators of Max Sauter. A scholar is included among the top collaborators of Max Sauter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Sauter. Max Sauter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sauter, Max, et al.. (2025). Effect of Staggered vs. Simultaneous Co-Administration of Bempedoic Acid on Pharmacokinetics of Pravastatin: Randomized, Cross-Over Clinical Trial in Healthy Volunteers. Pharmaceutics. 17(1). 60–60. 1 indexed citations

Sauter, Max, Andreas D. Meid, Jürgen Burhenne, et al.. (2024). Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort. Clinical Pharmacology in Drug Development. 13(3). 297–306. 2 indexed citations

Burhenne, Jürgen, et al.. (2024). A Highly Sensitive UPLC-MS/MS Method for the Quantification of the Organic Cation Transporters’ Mediated Metformin Uptake and Its Inhibition in Cells. Molecules. 29(21). 5162–5162. 1 indexed citations

Burhenne, Jürgen, et al.. (2024). In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto reductases. Archives of Toxicology. 98(3). 807–820. 1 indexed citations

Rigalli, Juan Pablo, Antje Blank, Jürgen Burhenne, et al.. (2024). Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP). International Journal of Molecular Sciences. 25(7). 4118–4118. 3 indexed citations

Mikus, Gerd, Max Sauter, Jürgen Burhenne, et al.. (2023). Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin. Cardiovascular Drugs and Therapy. 39(2). 325–335. 1 indexed citations

Uhl, Philipp, Dominik Witzigmann, Stefan Zimmermann, et al.. (2023). A Nanocarrier Approach for Oral Peptide Delivery: Evaluation of Cell‐Penetrating‐Peptide‐Modified Liposomal Formulations in Dogs. Advanced Therapeutics. 6(10). 7 indexed citations

Haefeli, Walter E., et al.. (2022). Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC3A2) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine. International Journal of Molecular Sciences. 23(7). 3637–3637. 10 indexed citations

Burghaus, Ina, Max Sauter, Peter W. Rose, et al.. (2022). Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide—An Exploratory Phase I Clinical Trial. International Journal of Molecular Sciences. 23(24). 15924–15924. 5 indexed citations

10.

Burhenne, Jürgen, et al.. (2022). Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides. Pharmaceutics. 14(8). 1610–1610. 4 indexed citations

11.

Benzel, Julia, Philipp Uhl, Abigail Davis, et al.. (2021). Investigating the Central Nervous System Disposition of Actinomycin D: Implementation and Evaluation of Cerebral Microdialysis and Brain Tissue Measurements Supported by UPLC-MS/MS Quantification. Pharmaceutics. 13(9). 1498–1498. 3 indexed citations

12.

Haefeli, Walter E., et al.. (2021). Rapid and Sensitive Quantification of Intracellular Glycyl-Sarcosine for Semi-High-Throughput Screening for Inhibitors of PEPT-1. Pharmaceutics. 13(7). 1019–1019. 7 indexed citations

13.

Sauter, Max, Kathrin I. Foerster, Julia Benzel, et al.. (2021). Bioanalysis of selinexor in mouse plasma micro-samples utilizing UPLC-MS/MS. Journal of Chromatography B. 1176. 122781–122781. 4 indexed citations

14.

Sauter, Max, Philipp Uhl, Jürgen Burhenne, & Walter E. Haefeli. (2020). Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis. 186. 113276–113276. 3 indexed citations

15.

Sauter, Max, Philipp Uhl, Andreas D. Meid, et al.. (2020). Reporter cell assay-based functional quantification of TNF-α-antagonists in serum – a proof-of-principle study for adalimumab. Analytical Biochemistry. 596. 113646–113646. 2 indexed citations

16.

Sauter, Max, Philipp Uhl, Jürgen Burhenne, & Walter E. Haefeli. (2020). Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS. Journal of Pharmaceutical Analysis. 10(3). 233–239. 7 indexed citations

17.

Uhl, Philipp, Max Sauter, Tammy C. T. Lan, et al.. (2018). Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model. OncoImmunology. 8(1). e1524694–e1524694. 13 indexed citations

18.

Roesch, Saskia, Thomas Lindner, Max Sauter, et al.. (2018). Comparison of the RGD Motif–Containing α_vβ₆Integrin–Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC. Journal of Nuclear Medicine. 59(11). 1679–1685. 42 indexed citations

19.

Altmann, Annette, Max Sauter, Saskia Roesch, et al.. (2017). Identification of a Novel ITGαvβ6-Binding Peptide Using Protein Separation and Phage Display. Clinical Cancer Research. 23(15). 4170–4180. 45 indexed citations

20.

Uhl, Philipp, Max Sauter, Walter Mier, et al.. (2016). Delivery of Copper-chelating Trientine (TETA) to the central nervous system by surface modified liposomes. International Journal of Pharmaceutics. 512(1). 87–95. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact